Literature DB >> 3026027

25-Hydroxylase activity in subcellular fractions from human liver. Evidence for different rates of mitochondrial hydroxylation of vitamin D2 and D3.

I Holmberg, T Berlin, S Ewerth, I Björkhem.   

Abstract

25-Hydroxylation of vitamin D2 and D3 was studied in subcellular fractions from human liver, using a technique based on isotope dilution-mass spectrometry. The mitochondrial fraction fortified with isocitrate catalysed 25-hydroxylation of vitamin D3 at a rate of about 10 pmol/mg protein X min. Under the same conditions, the rate of 25-hydroxylation of vitamin D2 was less than 2 pmol/mg protein X min. Crude microsomes fortified with NADPH catalysed 25-hydroxylation of vitamin D3 to a very low extent, and this activity was not linear with the amount of microsomal protein. A higher rate of conversion was obtained with a partially purified cytochrome P-450 fraction in the presence of NADPH-cytochrome P-450 reductase and NADPH. This fraction also catalysed 25-hydroxylation of 1 alpha-hydroxyvitamin D3 and 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha-triol. 25-Hydroxylation of vitamin D2 could not be detected, neither with crude microsomes, nor with the microsomal cytochrome P-450 fraction. Since the assay for 25-hydroxyvitamin D2 was less sensitive than that for 25-hydroxyvitamin D3, these experiments do not rule out the presence of some 25-hydroxylase activity towards vitamin D2 in the microsomes. The results are discussed in relation to previous work in which a lower toxicity has been reported for vitamin D2 than for vitamin D3 in some mammalian species.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3026027     DOI: 10.3109/00365518609084051

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  16 in total

1.  Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokinetics.

Authors:  Alanna S Ocampo-Pelland; Marc R Gastonguay; Matthew M Riggs
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-05-02       Impact factor: 2.745

Review 2.  Vitamin D Metabolism and Guidelines for Vitamin D Supplementation.

Authors:  Indra Ramasamy
Journal:  Clin Biochem Rev       Date:  2020-12

3.  Vitamin D 2 interacts with Human PrP(c) (90-231) and breaks PrP(c) oligomerization in vitro.

Authors:  Midori Suenaga; Yusuke Hiramoto; Yoichi Matsunaga
Journal:  Prion       Date:  2013-07-15       Impact factor: 3.931

4.  25-Hydroxylation of vitamin D3 by a cytochrome P-450 from rabbit liver mitochondria.

Authors:  H Dahlbäck; K Wikvall
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

5.  Purification of a cytochrome P-450 from pig kidney microsomes catalysing the 25-hydroxylation of vitamin D3.

Authors:  H Postlind; K Wikvall
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

Review 6.  Early pregnancy maternal vitamin D concentrations and risk of gestational diabetes mellitus.

Authors:  Dodie L Arnold; Daniel A Enquobahrie; Chungfang Qiu; Jonathan Huang; Nancy Grote; Ann VanderStoep; Michelle A Williams
Journal:  Paediatr Perinat Epidemiol       Date:  2015-03-23       Impact factor: 3.980

7.  De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase.

Authors:  Jeffrey B Cheng; Daniel L Motola; David J Mangelsdorf; David W Russell
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

8.  Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions.

Authors:  Y D Guo; S Strugnell; D W Back; G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase.

Authors:  Jeffrey B Cheng; Michael A Levine; Norman H Bell; David J Mangelsdorf; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

Review 10.  Vitamin D and diabetes mellitus.

Authors:  Liviu G Danescu; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2008-11-01       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.